J
James R. O'Dell
Researcher at University of Nebraska Medical Center
Publications - 174
Citations - 13816
James R. O'Dell is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 48, co-authored 167 publications receiving 12384 citations. Previous affiliations of James R. O'Dell include Veterans Health Administration & University of Florence.
Papers
More filters
Journal ArticleDOI
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh,Kenneth G. Saag,S. Louis Bridges,Elie A. Akl,Raveendhara R. Bannuru,Matthew C. Sullivan,Elizaveta E. Vaysbrot,Christine McNaughton,Mikala C. Osani,Robert H. Shmerling,Jeffrey R. Curtis,Daniel E. Furst,Deborah Parks,Arthur Kavanaugh,James R. O'Dell,Charles H. King,Amye Leong,Eric L. Matteson,John T. Schousboe,Barbara E. Drevlow,Seth Ginsberg,James Grober,E. William St. Clair,Elizabeth A. Tindall,Amy S. Miller,Timothy E. McAlindon +25 more
TL;DR: To develop a new evidence‐based, pharmacologic treatment guideline for rheumatoid arthritis (RA), a large number of patients with RA are referred to a single clinic for treatment with these medications.
Journal ArticleDOI
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Daniel O. Clegg,Domenic J. Reda,Crystal L. Harris,Marguerite A. Klein,James R. O'Dell,Michele Hooper,John D. Bradley,Clifton O. Bingham,Michael H. Weisman,Christopher G. Jackson,Nancy E Lane,John J. Cush,Larry W. Moreland,H. Ralph Schumacher,Chester V. Oddis,Frederick Wolfe,Jerry A. Molitor,David E. Yocum,Thomas J. Schnitzer,Daniel E. Furst,Allen D. Sawitzke,Helen Shi,Kenneth D. Brandt,Roland W. Moskowitz,H. James Williams +24 more
TL;DR: The GAIT trial as discussed by the authors evaluated the efficacy and safety of glucosamine and chondroitin sulfate as a treatment for knee pain from osteoarthritis in 1583 patients.
Journal ArticleDOI
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA Treatment Recommendations
Jasvinder A. Singh,Kenneth G. Saag,S. Louis Bridges,Elie A. Akl,Raveendhara R. Bannuru,Matthew C. Sullivan,Elizaveta E. Vaysbrot,Christine McNaughton,Mikala C. Osani,Robert H. Shmerling,Jeffrey R. Curtis,Daniel E. Furst,Deborah Parks,Arthur Kavanaugh,James R. O'Dell,Charles H. King,Amye Leong,Eric L. Matteson,John T. Schousboe,Barbara E. Drevlow,Seth Ginsberg,James Grober,E. William St. Clair,Elizabeth A. Tindall,Amy S. Miller,Timothy E. McAlindon +25 more
TL;DR: To develop a new evidence‐based, pharmacologic treatment guideline for rheumatoid arthritis (RA), a large number of patients with RA are referred to a single clinic for treatment with these medications.
Journal ArticleDOI
Rheumatoid Arthritis Disease Activity Measures: American College of Rheumatology Recommendations for Use in Clinical Practice
Jaclyn Anderson,Liron Caplan,Jinoos Yazdany,Mark L. Robbins,Tuhina Neogi,Kaleb Michaud,Kenneth G. Saag,James R. O'Dell,Salahuddin Kazi +8 more
TL;DR: The American College of Rheumatology as mentioned in this paper conducted a systematic review of the literature to identify rheumatoid arthritis (RA) disease activity measures using exclusion criteria, input from an Expert Advisory Panel and psychometric analysis, a list of potential measures was created.
Journal ArticleDOI
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
Larry W. Moreland,James R. O'Dell,Harold E. Paulus,Jeffrey R. Curtis,Joan M. Bathon,E. William St. Clair,S. Louis Bridges,Jie Zhang,Theresa McVie,George Howard,Désirée van der Heijde,Stacey S. Cofield +11 more
TL;DR: Initial use of MTX monotherapy with the addition of sulfasalazine plus hydroxychloroquine (or etanercept, if necessary, after 6 months) is a reasonable therapeutic strategy for patients with early RA.